NEWSLETTER

By clicking submit, you agree to share your email address with TFN to receive marketing, updates, and other emails from the site owner. Use the unsubscribe link in the emails to opt out at any time.

IntelliProve raises €2.7M from Miles Ahead to turn any camera into a health sensor

IntelliProve team
Image credits: IntelliProve
  • Belgian healthtech startup secures €2.7M seed funding led by Miles Ahead.
  • Its software measures six health biomarkers through a 30-second face scan.
  • IntelliProve is taking its face scan from virtual care into humanoid robots.

Smartphones and laptops have cameras that people use every day, but these devices have largely stayed separate from personal health monitoring. Belgian healthtech startup IntelliProve wants to change that by turning standard cameras into tools that can measure vital signs without wearables, blood pressure cuffs or other dedicated devices.

The Ghent-based company has raised €2.7M in seed funding to take its camera-based health sensing from virtual care into humanoid robots and other connected devices. 

Miles Ahead, a Belgian early-stage fund that manages €30M, led the round. Wit-Gele Kruis (The White and Yellow Cross), imec.istart and several business angels also took part. The money will go towards research, measurement accuracy, clinical validation and certification in markets beyond Europe.

It is IntelliProve’s third announced round. The company raised a €1M seed in November 2022 and a €1.25M seed in January 2025, which Miles Ahead also led.

Turning cameras into health monitoring tools

IntelliProve’s software uses a 30-second face scan to measure six biomarkers: heart rate, heart rate variability (HRV), respiratory rate, systolic and diastolic blood pressure, and resonant breathing.

The technology is based on remote photoplethysmography (rPPG). Each heartbeat pushes blood through the face and changes the colour of the skin very slightly, which is invisible to the eye but measurable by a camera. The software reads those changes alongside the small movements of breathing to extract physiological signals through a standard camera.

Movement, changing light and different cameras make that hard in practice, so IntelliProve says it built three proprietary technologies: VitalMesh tracks facial skin, PulseShape estimates vital signs from the pulse signal, and TripleGate checks quality on the video, the signal and the final values.

According to IntelliProve, its models have been tested and validated on more than 6 million data points. The company says virtual care, health insurance and wellbeing platforms in more than 50 countries use the technology, with partners embedding it in their own branded apps.

From virtual care to humanoid robots

In virtual care, users complete health check-ins at home on a smartphone or laptop. The company says the readings can give clinicians data before a teleconsultation and add an objective layer to online triage. 

The next target is humanoid robots. Robots entering homes and care facilities already use cameras to navigate, but cannot tell how the person in front of them is doing. 

IntelliProve wants a robot to run the same 30-second scan through that camera, with no extra hardware. In elderly care, the company says, that would give carers more context about a resident. The robot passes the values on, and a person decides what happens next.

The company says it works with selected robotics partners, which it has not named, and sees further uses in smart glasses and self-service kiosks.

“Healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone,” said Joeri Tulkens, co-founder and co-CEO of IntelliProve. 

“Our virtual care partners are not just experimenting with IntelliProve, they are building it into the core of their offering. Humanoid robots are next: they are becoming very good at understanding the world around them, and the next step is helping them understand the people within that world,” he added. 

Founders focus on scientific validation and global expansion

IntelliProve was founded in 2021 by Tulkens, Tanguy Sanglet, who is CTO, Brecht Dhuyvetters and Maxime Mattelin. It works with TU Delft and Ghent University Hospital, and holds ISO 27001 certification. It is also pursuing CE marking as a Class IIa medical device under the EU Medical Device Regulation.

The funding will widen its datasets across skin tones, ages, lighting conditions and cameras, and improve accuracy biomarker by biomarker, starting with blood pressure and HRV, benchmarked against cuffs and breathing belts.

“We will keep investing heavily in research, scientific validation and high-quality data, and we want our layer certified in markets around the world. Whether the scan runs on a smartphone or on a humanoid robot, the bar stays the same: the best health sensing layer in the world,” said Sanglet.

“IntelliProve has built its face scan technology with virtual care platforms in more than 50 countries. The company has developed a unique technology with a clear focus on scientific validation and certification. It’s now ready to scale at large with a meaningful impact on millions of lives,” said Luc Burgelman, founder of Miles Ahead.

Competitors and the remote monitoring market

Camera-based vitals are not new: Israeli company Binah.ai, which also uses rPPG, raised a $13.5M Series B in June 2020. 

Others come at the problem differently. YOU(th) Health Tech raised $4.5M in February 2026 for smartphone screening that reads selfies and voice to detect more than 50 biomarkers. smedo closed a €1.66M seed round in April 2022 for a sensor-based contactless vital-sign monitor aimed at hospitals and nursing homes. Hilo raised a $19M Series B extension in July 2026 for a wrist-worn blood pressure sensor that relies on cuff calibration.

According to Grand View Research, the global remote patient monitoring systems market was worth $26 billion in 2025 and should reach $110.7 billion by 2033, a compound annual growth rate of 20% between 2026 and 2033. Camera sensing is only a slice of that market, but it runs on devices people already own.

Can a 30-second face scan become a routine part of how people, and the machines that care for them, check on health?

Total
0
Shares
Related Posts
Total
0
Share
tfn-logo-2-220x220-removebg-preview

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you
TFN Banner